Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Essen Biotech
Shenzhen Second People's Hospital
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
University of Kentucky
Northwestern University